EXELIXIS (EXEL) stock: insider trades, news & valuation
Net sellingShare price and insider trades
EXELIXIS insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $1.2M and 12 sold $42.2M of EXEL stock on the open market.
Get emailed when insiders cluster-buy stocks like EXEL
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
EXEL insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $527K | 1 |
| Q2 2026 | — | 0 | $10.6M | 9 |
| Q1 2026 | — | 0 | $20.6M | 14 |
| Q4 2025 | $1.2M | 1 | $10.5M | 8 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 EXELIXIS, INC. insider reported open-market purchases totaling $1.2M, while 12 insiders reported sales totaling $42.2M. 7 of 32 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 12SEC | Mary C BeckerleDirector | Sell Plan | 9,81216,079 held (−38%) | $53.66 | $527K | +11.6% | — |
| Jun 3SEC | Sue Gail EckhardtDirector | Sell Plan | 9,81216,079 held (−38%) | $50.14 | $492K | +19.4% | — |
| Jun 3SEC | Jack L WyszomierskiDirector | Sell Plan | 3,925284,384 held (−1%) | $50.55 | $198K | +18.4% | — |
| May 28SEC | Dana AftabEvp, Research And Development | Sell | 43,451594,741 held (−7%) | $50.35 | $2.2M | +18.9% | — |
| May 22SEC | Patrick J. HaleyEvp, Commercial | Sell | 32,110357,638 held (−8%) | $49.81 | $1.6M | +20.2% | — |
| May 19SEC | Christopher J. SennerCFO | Sell | 34,901952,317 held (−4%) | $50.00 | $1.7M | +19.7% | — |
| May 19SEC | Brenda HeftiGeneral Counsel | Sell Plan | 6,625106,762 held (−6%) | $50.21 | $333K | +19.2% | — |
| May 8SEC | George PosteDirector | Sell | 60,000118,832 held (−34%) | $45.71 | $2.7M | +31.0% | — |
| May 8SEC | Maria C FreireDirector | Sell | 20,634100,819 held (−17%) | $46.00 | $949K | +30.1% | — |
| May 8SEC | Mary C BeckerleDirector | Sell | 7,71217,524 held (−31%) | $48.45 | $374K | +23.6% | — |
| Feb 26SEC | Dana AftabEvp, Research And Development | Sell | 47,918616,106 held (−7%) | $44.50 | $2.1M | +34.5% | — |
| Feb 23SEC | Dana AftabEvp, Research And Development | Sell | 29,873664,024 held (−4%) | $44.35 | $1.3M | +35.0% | — |
| Feb 20SEC | Jack L WyszomierskiDirector | Sell Plan | 99,574279,942 held (−26%) | $44.01 | $4.4M | +36.0% | — |
| Feb 19SEC | Julie SmithDirector | Sell | 44,08720,590 held (−68%) | $44.50 | $2.0M | +34.5% | — |
| Feb 19SEC | Julie SmithDirector | Sell | 42,42220,590 held (−67%) | $43.33 | $1.8M | +38.1% | — |
| Feb 19SEC | Julie SmithDirector | Sell | 20,03020,590 held (−49%) | $44.30 | $887K | +35.1% | — |
| Feb 18SEC | Patrick J. HaleyEvp, Commercial | Sell | 64,778381,908 held (−15%) | $43.50 | $2.8M | +37.6% | — |
| Feb 18SEC | Christopher J. SennerCFO | Sell | 34,2781,042,579 held (−3%) | $43.00 | $1.5M | +39.2% | — |
| Feb 18SEC | Christopher J. SennerCFO | Sell | 30,617976,092 held (−3%) | $43.67 | $1.3M | +37.1% | — |
| Feb 18SEC | Bob OliverDirector | Sell | 21,16221,120 held (−50%) | $43.90 | $929K | +36.4% | — |
| Feb 18SEC | Brenda HeftiGeneral Counsel | Sell Plan | 18,66996,512 held (−16%) | $44.01 | $822K | +36.0% | — |
| Feb 18SEC | Bob OliverDirector | Sell | 9,08842,282 held (−18%) | $43.61 | $396K | +37.3% | — |
| Feb 18SEC | Sue Gail EckhardtDirector | Sell Plan | 3,85617,524 held (−18%) | $43.79 | $169K | +36.7% | — |
| Feb 18SEC | Patrick J. HaleyEvp, Commercial | Sell | 3,036446,686 held (−1%) | $43.84 | $133K | +36.5% | — |
| Nov 26SEC | Caligan Partners LpSee Remarks | Buy | 27,5321,553,262 held (+2%) | $43.12 | $1.2M | +38.8% | — |
| Nov 24SEC | Patrick J. HaleyEvp, Commercial | Sell | 28,043374,029 held (−7%) | $42.58 | $1.2M | +40.6% | — |
| Nov 24SEC | Patrick J. HaleyEvp, Commercial | Sell | 23,539 | $41.93 | $987K | +42.8% | — |
| Nov 24SEC | Patrick J. HaleyEvp, Commercial | Sell | 10,648 | $41.77 | $445K | +43.3% | — |
| Nov 24SEC | Patrick J. HaleyEvp, Commercial | Sell | 10,000402,072 held (−2%) | $42.11 | $421K | +42.2% | — |
| Nov 13SEC | Stelios PapadopoulosDirector | Sell | 100,0001,189,228 held (−8%) | $43.55 | $4.4M | +37.5% | — |
| Nov 13SEC | Dana AftabEvp, Research And Development | Sell | 48,383664,778 held (−7%) | $42.50 | $2.1M | +40.8% | — |
| Nov 13SEC | Mary C BeckerleDirector | Sell | 18,83821,380 held (−47%) | $41.90 | $789K | +42.9% | — |
| Nov 13SEC | Mary C BeckerleDirector | Sell | 5,78440,218 held (−13%) | $42.03 | $243K | +42.4% | — |
Insiders at EXELIXIS, INC.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Dana AftabEvp, Research And Development | — | $7.7M | May 28, 2026 | — |
| Patrick J. HaleyEvp, Commercial | — | $7.6M | May 22, 2026 | — |
| Julie SmithDirector | — | $4.7M | Feb 19, 2026 | — |
| Jack L WyszomierskiDirector | — | $4.6M | Jun 3, 2026 | — |
| Christopher J. SennerCFO | — | $4.6M | May 19, 2026 | — |
| Stelios PapadopoulosDirector | — | $4.4M | Nov 13, 2025 | — |
| Caligan Partners LpSee Remarks | $1.2M | — | Nov 26, 2025 | — |
| George PosteDirector | — | $2.7M | May 8, 2026 | — |
| Mary C BeckerleDirector | — | $1.9M | Aug 12, 2026 | — |
| Bob OliverDirector | — | $1.3M | Feb 18, 2026 | — |
| Brenda HeftiGeneral Counsel | — | $1.2M | May 19, 2026 | — |
| Maria C FreireDirector | — | $949K | May 8, 2026 | — |
| Sue Gail EckhardtDirector | — | $661K | Jun 3, 2026 | — |
EXEL stock: common questions
Are EXELIXIS, INC. insiders buying EXEL stock?
In the past 12 months, 1 insiders reported open-market purchases of EXEL worth $1.2M. The latest was See Remarks Caligan Partners Lp bought $1.2M of EXEL at $43.12 — first open-market purchase in our records.
Are EXELIXIS, INC. insiders selling EXEL stock?
12 insiders reported sales worth $42.2M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is EXEL's 52-week range?
Over the past year EXEL has traded between $34.54 and $59.86. It last closed at $59.86 on Oct 9, 2026.